Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Cardiovascular Drugs and Therapy|June 18, 1999
Selective tyrosine kinase inhibitor for the platelet-derived growth factor receptor in vitro inhibits smooth muscle cell proliferation after reinjury of arterial intima in vivoM Myllärniemi, J Frösen, L G Calderón Ramirez, et al.Circulation|May 5, 1999
Prevention of cardiac allograft arteriosclerosis by protein tyrosine kinase inhibitor selective for platelet-derived growth factor receptorR Sihvola, P Koskinen, M Myllärniemi, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1996
Rat cytomegalovirus infection and chronic kidney allograft rejectionP K Koskinen, S Yilmaz, E Kallio, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
Enhancement of transplantation-associated atherosclerosis by CMV, which can be prevented by antiviral therapy in the form of HPMPCJ H Bruning, M Persoons, K Lemström, et al.The Clinical Investigator|September 1, 1992
Towards understanding the pathophysiology of chronic rejectionP Häyry, A Mennander, S Yilmaz, et al.The Journal of Experimental Medicine|October 1, 1995
De novo expression of endothelial sialyl Lewis(a) and sialyl Lewis(x) during cardiac transplant rejection: superior capacity of a tetravalent sialyl Lewis(x) oligosaccharide in inhibiting L-selectin-dependent lymphocyte adhesionJ P Turunen, M L Majuri, A Seppo, et al.Transplantation Proceedings|December 21, 2010
Control of early Aspergillus mortality after lung transplantation: outcome and risk factorsM Eriksson, K Lemström, R Suojaranta-Ylinen, et al.Pageof 2